Form 8-K - Current report:
SEC Accession No. 0001104659-22-061294
Filing Date
2022-05-16
Accepted
2022-05-16 16:06:44
Documents
12
Period of Report
2022-05-10
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2215166d2_8k.htm   iXBRL 8-K 26371
  Complete submission text file 0001104659-22-061294.txt   199099

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rzlt-20220510.xsd EX-101.SCH 3042
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rzlt-20220510_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rzlt-20220510_pre.xml EX-101.PRE 22601
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2215166d2_8k_htm.xml XML 3605
Mailing Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065
Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315 REDWOOD CITY CA 94065 650-847-1919
Rezolute, Inc. (Filer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39683 | Film No.: 22928829
SIC: 2834 Pharmaceutical Preparations